• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MALAT1 通过增加 DCP1A 表达和下调 miR203 促进结直肠癌恶性转化。

MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation.

机构信息

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Mol Carcinog. 2018 Oct;57(10):1421-1431. doi: 10.1002/mc.22868. Epub 2018 Jul 12.

DOI:10.1002/mc.22868
PMID:29964337
Abstract

The long non-coding RNA MALAT1 has been proved to promote the cell proliferation, drug resistance, invasion, and metastasis of colorectal cancer (CRC) in vitro and in vivo by regulating the expression of various oncogenes and their protein products. Our previous work discovered that the expression of the mRNA-decapping enzymes 1a (DCP1A) is upregulated in CRCs. However, the relationships between MALAT1 and DCP1A in the development of CRC and the underlying mechanisms are still unclear. In this study, we investigated the molecular mechanisms by which MALAT1 and DCP1A may be linked to contribute to the malignancies of CRCs. We found that DCP1A is a direct target molecule of MALAT1. Moreover, by screening the downstream genes of MALAT1, we noticed that microRNA 203(miR203), an oncogene suppressor in numerous cancers, is inversely correlated to both MALAT1 and DCP1A expressions. Following MALAT1 knockdown, we observed overexpression of miR203 accompanied with DCP1A downregulation to a level that reversed the promoted cell proliferation, invasion, and migration in vitro and in vivo, which could be restored by miR203 knockdown or DCP1A overexpression. These results proposed a new molecular mechanism of MALAT-miR203-DCP1A axis which is involved with the development and contributes to the malignancy of colorectal cancers.

摘要

长链非编码 RNA MALAT1 已被证明可通过调节各种癌基因及其蛋白产物的表达,在体内外促进结直肠癌(CRC)的细胞增殖、耐药性、侵袭和转移。我们之前的工作发现,mRNA 去帽酶 1a(DCP1A)的表达在 CRCs 中上调。然而,MALAT1 和 DCP1A 在 CRC 发展中的关系及其潜在机制仍不清楚。在这项研究中,我们研究了 MALAT1 和 DCP1A 可能相互作用的分子机制,以促进 CRC 的恶性发展。我们发现 DCP1A 是 MALAT1 的直接靶分子。此外,通过筛选 MALAT1 的下游基因,我们注意到 miR203(一种在许多癌症中作为致癌基因抑制剂的 microRNA)与 MALAT1 和 DCP1A 的表达呈负相关。在 MALAT1 敲低后,我们观察到 miR203 的过表达伴随着 DCP1A 的下调,其水平可逆转体外和体内促进的细胞增殖、侵袭和迁移,这可通过 miR203 敲低或 DCP1A 过表达来恢复。这些结果提出了 MALAT-miR203-DCP1A 轴参与结直肠癌发展并有助于其恶性发展的新分子机制。

相似文献

1
MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation.MALAT1 通过增加 DCP1A 表达和下调 miR203 促进结直肠癌恶性转化。
Mol Carcinog. 2018 Oct;57(10):1421-1431. doi: 10.1002/mc.22868. Epub 2018 Jul 12.
2
Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.长链非编码 RNA TP73-AS1 通过海绵吸附 miR-194 促进结直肠癌细胞增殖、迁移和侵袭并上调 TGFα。
Cancer Biomark. 2018;23(1):145-156. doi: 10.3233/CBM-181503.
3
Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.长链非编码 RNA MALAT1 通过靶向 miR-22-3p 调控 PI3K/Akt 通路影响肾透明细胞癌细胞活力和迁移。
Oncol Rep. 2019 Feb;41(2):1113-1121. doi: 10.3892/or.2018.6853. Epub 2018 Nov 6.
4
Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer.抑制 MALAT1 可降低结直肠癌的肿瘤生长和转移,并提高药物敏感性。
Cell Signal. 2019 May;57:21-28. doi: 10.1016/j.cellsig.2019.01.013. Epub 2019 Feb 1.
5
The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1.人类RNA监测因子UPF1通过靶向长链非编码RNA MALAT1调节胃癌进展。
Cell Physiol Biochem. 2017;42(6):2194-2206. doi: 10.1159/000479994. Epub 2017 Aug 15.
6
MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1.MALAT1通过调节IQGAP1的表达促进甲状腺癌细胞的增殖和侵袭。
Biomed Pharmacother. 2016 Oct;83:1-7. doi: 10.1016/j.biopha.2016.05.039. Epub 2016 Jun 15.
7
Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.长链非编码 RNA GAS5 和 microRNA-221 在结直肠癌中的预后和预测价值及其对结直肠癌细胞增殖、迁移和侵袭的影响。
Cancer Biomark. 2018;22(2):283-299. doi: 10.3233/CBM-171011.
8
Down-regulated long non-coding RNA SNHG1 inhibits tumor genesis of colorectal carcinoma.下调的长链非编码RNA SNHG1抑制结直肠癌的肿瘤发生。
Cancer Biomark. 2017 Jul 19;20(1):67-73. doi: 10.3233/CBM-170112.
9
Long non-coding RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed SRSF1 phosphorylation in colorectal cancer cells.长链非编码RNA MALAT1通过促进SRPK1催化的SRSF1磷酸化来增加结直肠癌细胞中AKAP-9的表达。
Oncotarget. 2016 Mar 8;7(10):11733-43. doi: 10.18632/oncotarget.7367.
10
Long Noncoding RNA MALAT1 Promotes Colorectal Cancer Progression by Acting as a ceRNA of miR-508-5p to Regulate RAB14 Expression.长链非编码 RNA MALAT1 通过作为 miR-508-5p 的 ceRNA 来调节 RAB14 表达促进结直肠癌进展。
Biomed Res Int. 2020 Dec 4;2020:4157606. doi: 10.1155/2020/4157606. eCollection 2020.

引用本文的文献

1
p53 transcriptionally activates DCP1B to suppress tumor progression and enhance tumor sensitivity to PI3K blockade in non-small cell lung cancer.p53通过转录激活DCP1B来抑制非小细胞肺癌的肿瘤进展并增强肿瘤对PI3K阻断的敏感性。
Cell Death Differ. 2025 Apr 9. doi: 10.1038/s41418-025-01501-y.
2
Human DCP1 is crucial for mRNA decapping and possesses paralog-specific gene regulating functions.人 DCP1 对 mRNA 脱帽至关重要,并具有具有平行基因特异性的基因调控功能。
Elife. 2024 Nov 1;13:RP94811. doi: 10.7554/eLife.94811.
3
YAP/TAZ enhances P-body formation to promote tumorigenesis.
YAP/TAZ增强P小体形成以促进肿瘤发生。
Elife. 2024 Jul 24;12:RP88573. doi: 10.7554/eLife.88573.
4
Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.竞争性内源性 RNA 网络:解析长非编码 RNA 和环状 RNA 在结直肠癌化疗耐药中的作用。
J Cell Mol Med. 2024 Apr;28(7):e18197. doi: 10.1111/jcmm.18197.
5
Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy.胃肠道癌中的肿瘤细胞干性:调控与靶向治疗
Front Mol Biosci. 2024 Feb 22;10:1297611. doi: 10.3389/fmolb.2023.1297611. eCollection 2023.
6
lncRNA-disease association prediction based on the weight matrix and projection score.基于权重矩阵和投影得分的 lncRNA-疾病关联预测。
PLoS One. 2023 Jan 3;18(1):e0278817. doi: 10.1371/journal.pone.0278817. eCollection 2023.
7
Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis.基于文献计量分析的长链非编码RNA(lncRNAs)在结直肠癌(CRC)中的综合概况及未来展望
Noncoding RNA Res. 2022 Oct 11;8(1):33-52. doi: 10.1016/j.ncrna.2022.10.001. eCollection 2023 Mar.
8
MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.MALAT1-miRNAs 网络调节胸苷酸合成酶并影响基于 5FU 的化疗。
Mol Med. 2022 Aug 3;28(1):89. doi: 10.1186/s10020-022-00516-2.
9
MALAT1-related signaling pathways in colorectal cancer.结直肠癌中与MALAT1相关的信号通路。
Cancer Cell Int. 2022 Mar 19;22(1):126. doi: 10.1186/s12935-022-02540-y.
10
Processing body (P-body) and its mediators in cancer.癌症中的加工体(P小体)及其介质
Mol Cell Biochem. 2022 Apr;477(4):1217-1238. doi: 10.1007/s11010-022-04359-7. Epub 2022 Jan 28.